INIS
children
100%
india
72%
neonates
49%
levels
43%
comparative evaluations
36%
patients
33%
diseases
31%
control
28%
therapy
27%
thalassemia
25%
vitamin d
22%
hospitals
21%
mortality
19%
resources
18%
cancer
18%
insulin
17%
fever
17%
leukemia
17%
communities
17%
hiv
17%
quality of life
17%
eyes
17%
risks
16%
congenital diseases
16%
immunoglobulins
15%
drugs
13%
pediatrics
13%
antibiotics
12%
units
12%
staphylococcus
12%
populations
12%
tools
11%
values
10%
transmission
10%
homocysteine
10%
oxidation
10%
chemotherapy
10%
genetics
10%
adults
10%
learning
10%
colleges
10%
liver
9%
teaching
9%
glucose
9%
triglycerides
9%
iron
9%
schools
9%
tissues
9%
sensitivity
8%
weight
8%
Medicine and Dentistry
Child
61%
Therapeutic Procedure
21%
Combination Therapy
17%
Vitamin D
17%
Thalassemia Major
17%
Association
13%
Hospital
12%
Neonates
11%
Patient
10%
Infection
10%
Drug
9%
Chemotherapeutic Agent
9%
Cross Sectional Study
9%
Case Report
9%
Malignant Neoplasm
9%
Experience
9%
Immunoglobulin
9%
Tertiary Care
8%
Glomerulonephritis
8%
Infant
8%
Gangrene
8%
Acute Lymphoblastic Leukemia
8%
Necrotizing Fasciitis
8%
Asthma
8%
Pediculosis
8%
Hormone Response
8%
Hypovitaminosis
8%
Heart Left Ventricle Function
8%
Syndrome
8%
Interleukin 6
8%
Cystinosis
8%
Adolescent
8%
C Reactive Protein
8%
Immunity
8%
Fanconi Syndrome
8%
Glucosuria
8%
Rickets
8%
Cataract
8%
Young Adult
8%
Immune Deficiency
8%
Brain Stem Response
8%
Dengue Fever
8%
Erythema Multiforme
8%
Quality of Life
8%
Iron Overload
8%
Prospective Study
8%
Beta Thalassemia
8%
Childhood
8%
Human Immunodeficiency Virus
8%
Hyperreflexia
8%
Nursing and Health Professions
Child
29%
Insulin Resistance
17%
Neonates
15%
Control
10%
Vitamin D
10%
Prematurity
10%
Device Material
10%
Glucose
10%
Vitamin Deficiency
9%
Disease Severity
9%
Scoring System
9%
Jaundice
8%
Sepsis
8%
Parathyroid Hormone
8%
Triacylglycerol
8%
Asthma
8%
Antioxidant
8%
Dyslipidemia
8%
Obesity
8%
Meta Analysis
8%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
8%
Acute Lymphoblastic Leukemia
8%
Case-Control Study
8%
Inpatient
8%
Childhood Cancer
8%
Phototherapy
8%
Survival
8%
Dysphagia
8%
Validity
8%
Newborn Disease
8%
Combination Therapy
8%
Pneumothorax
8%
Homeostasis Model Assessment
6%
